NFRKB Antikörper (AA 270-994)
Kurzübersicht für NFRKB Antikörper (AA 270-994) (ABIN7873155)
Target
Alle NFRKB Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 270-994
-
Verwendungszweck
- NFRKB Antibody / Nuclear factor related to kappa-B-binding protein
-
Aufreinigung
- Antigen affinity purified
-
Immunogen
- E. coli-derived recombinant human protein (amino acids H270-L994) was used as the immunogen for the NFRKB antibody.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal dilution of the NFRKB antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Buffer
- 0.5 mg/mL if reconstituted with 0.2 mL sterile DI water
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- After reconstitution, the NFRKB antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
-
-
- NFRKB (Nuclear Factor Related To KappaB Binding Protein (NFRKB))
-
Andere Bezeichnung
- NFRKB
-
Hintergrund
- NFRKB (nuclear factor related to kappa-B-binding protein) was first identified as a factor that could bind a variant NF-kappa B site in the interleukin-2 receptor alpha (IL-2R alpha) gene. NFRKB appears to be a transcription factor central to immune cell development. Evidence of this comes from the identification of NFRKB as an amplified gene in several cases of acute myeloid leukemia. Additionally, in another clinical case, a partial deletion of the chromosomal region that includes NFRKB is shown to be associated with combined cellular immunodeficiency.
-
UniProt
- Q6P4R8
Target
-